Literature DB >> 31486860

[Transcatheter aortic valve replacement : PARTNER 3 trial and Evolut Low Risk Trial].

C Frerker1, S Baldus2, S Nitschmann3.   

Abstract

Mesh：

Year:  2019        PMID： 31486860     DOI： 10.1007/s00108-019-00663-5

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  2 in total

1.  Durability of Transcatheter and Surgical Bioprosthetic Aortic Valves in Patients at Lower Surgical Risk.

Authors:  Lars Søndergaard; Nikolaj Ihlemann; Davide Capodanno; Troels H Jørgensen; Henrik Nissen; Bo Juel Kjeldsen; Yanping Chang; Daniel Andreas Steinbrüchel; Peter Skov Olsen; Anna Sonia Petronio; Hans Gustav Hørsted Thyregod
Journal:  J Am Coll Cardiol       Date:  2019-02-12       Impact factor: 24.094

2.  Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY).

Authors:  Raffi Bekeredjian; Gabor Szabo; Ümniye Balaban; Sabine Bleiziffer; Timm Bauer; Stephan Ensminger; Christian Frerker; Eva Herrmann; Friedhelm Beyersdorf; Christian Hamm; Andreas Beckmann; Helge Möllmann; Matthias Karck; Hugo A Katus; Thomas Walther
Journal:  Eur Heart J       Date:  2019-05-01       Impact factor: 29.983
  2 in total
  1 in total

1.  Incidence of Early Atrial Fibrillation After Transcatheter versus Surgical Aortic Valve Replacement: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Haider Altaii; Ramez Morcos; Fady Riad; Halah Abdulameer; Houman Khalili; Brijeshwar Maini; Eric Lieberman; Yoel Vivas; Phi Wiegn; Jose A Joglar; Judith Mackall; Sadeer G Al-Kindi; Sergio Thal
Journal:  J Atr Fibrillation       Date:  2020-12-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.